Amanote Research

Amanote Research

    RegisterSign In

Live or Let Die: Will the Courts Recognize in Terminally Ill Patients a Fundamental Right to Choose Non-Fda Approved Drugs or Does the FDA's Stringent Approval Process Carry Sufficient Merit?

Indiana Health Law Review
doi 10.18060/16523
Full Text
Open PDF
Abstract

Available in full text

Date

January 1, 2008

Authors
Clayton R. Portell
Publisher

IUPUI University Library


Related search

Withdrawal Life Support and Let Dying Ill Patients: Right or Wrong Decision

Journal of Clinical Research & Bioethics
2014English

Activation of P-TEFb by RBM7: To Live or Let Die

Molecular Cell
Cell BiologyMolecular Biology
2019English

Light, Lipids and Photoreceptor Survival: Live or Let Die?

Photochemical and Photobiological Sciences
Theoretical ChemistryPhysical
2015English

41 Extremely Low Birthweight Infants: Live or Let Die?

Pediatric Research
Child HealthPediatricsPerinatology
1991English

Should Terminally Ill Patients Have the Right to Take Drugs That Pass Phase I Testing? No

BMJ
2007English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

Predictive Maintenance!: To Do or Let Die

2014English

Possible FDA-approved Drugs to Treat Ebola Virus Infection

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy